Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling

被引:4
|
作者
De Sutter, Pieter-Jan [1 ]
Rossignol, Phebe [1 ]
Breens, Lien [1 ]
Gasthuys, Elke [1 ]
Vermeulen, An [1 ]
机构
[1] Univ Ghent, Dept Bioanal, B-9000 Ghent, Belgium
关键词
physiologically based pharmacokinetics (PBPK); pharmacokinetics; neonates; volume of distribution; allometric scaling; developmental pharmacology; HUMAN SERUM-ALBUMIN; SINGLE-DOSE PHARMACOKINETICS; POPULATION PHARMACOKINETICS; PROTEIN-BINDING; PRETERM INFANTS; CEFTAZIDIME PHARMACOKINETICS; CLINICAL PHARMACOKINETICS; MORPHINE PHARMACOKINETICS; IMIPENEM-CILASTATIN; HEALTHY-VOLUNTEERS;
D O I
10.3390/pharmaceutics15092348
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The volume of distribution at steady state (Vss) in neonates is still often estimated through isometric scaling from adult values, disregarding developmental changes beyond body weight. This study aimed to compare the accuracy of two physiologically based pharmacokinetic (PBPK) Vss prediction methods in neonates (Poulin & Theil with Berezhkovskiy correction (P & T+) and Rodgers & Rowland (R & R)) with isometrical scaling. PBPK models were developed for 24 drugs using in-vitro and in-silico data. Simulations were done in Simcyp (V22) using predefined populations. Clinical data from 86 studies in neonates (including preterms) were used for comparison, and accuracy was assessed using (absolute) average fold errors ((A)AFEs). Isometric scaling resulted in underestimated Vss values in neonates (AFE: 0.61), and both PBPK methods reduced the magnitude of underprediction (AFE: 0.82-0.83). The P & T+ method demonstrated superior overall accuracy compared to isometric scaling (AAFE of 1.68 and 1.77, respectively), while the R & R method exhibited lower overall accuracy (AAFE: 2.03). Drug characteristics (LogP and ionization type) and inclusion of preterm neonates did not significantly impact the magnitude of error associated with isometric scaling or PBPK modeling. These results highlight both the limitations and the applicability of PBPK methods for the prediction of Vss in the absence of clinical data.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Physiologically based pharmacokinetic modelling of oxycodone drug-drug interactions
    Rytkonen, Jaana
    Ranta, Veli-Pekka
    Kokki, Merja
    Kokki, Hannu
    Hautajarvi, Heidi
    Rinne, Valtteri
    Heikkinen, Aki T.
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2020, 41 (1-2) : 72 - 88
  • [42] Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption
    Neil A. Miller
    Rebecca H. Graves
    Chris D. Edwards
    Augustin Amour
    Ed Taylor
    Olivia Robb
    Brett O’Brien
    Aarti Patel
    Andrew W. Harrell
    Edith M. Hessel
    Clinical Pharmacokinetics, 2022, 61 : 281 - 293
  • [43] Physiologically-based pharmacokinetic modelling of distribution, bioaccumulation and excretion of POPs in Greenland sledge dogs (Canis familiaris)
    Sonne, Christian
    Gustavson, Kim
    Letcher, Robert J.
    Dietz, Rune
    ENVIRONMENTAL RESEARCH, 2015, 142 : 380 - 386
  • [44] Physiologically -based pharmacokinetic (PBPK) modelling of the rat eye: insights into ocular drug distribution after systemic administration
    Rimpela, Anna-Kaisa
    Ma, Guangda
    Freiwald, Matthias
    Sauer, Achim
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [45] Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly
    Stader, Felix
    Kinvig, Hannah
    Penny, Melissa A.
    Battegay, Manuel
    Siccardi, Marco
    Marzolini, Catia
    CLINICAL PHARMACOKINETICS, 2020, 59 (03) : 383 - 401
  • [46] Physiologically Based Pharmacokinetic Modelling to Identify Pharmacokinetic Parameters Driving Drug Exposure Changes in the Elderly
    Felix Stader
    Hannah Kinvig
    Melissa A. Penny
    Manuel Battegay
    Marco Siccardi
    Catia Marzolini
    Clinical Pharmacokinetics, 2020, 59 : 383 - 401
  • [47] Physiologically Based Pharmacokinetic Modelling of Inhaled Nemiralisib: Mechanistic Components for Pulmonary Absorption, Systemic Distribution, and Oral Absorption
    Miller, Neil A.
    Graves, Rebecca H.
    Edwards, Chris D.
    Amour, Augustin
    Taylor, Ed
    Robb, Olivia
    O'Brien, Brett
    Patel, Aarti
    Harrell, Andrew W.
    Hessel, Edith M.
    CLINICAL PHARMACOKINETICS, 2022, 61 (02) : 281 - 293
  • [48] Development of a Physiologically-Based Pharmacokinetic Model for Preterm Neonates: Evaluation with In Vivo Data
    Claassen, Karina
    Thelen, Kirstin
    Coboeken, Katrin
    Gaub, Thomas
    Lippert, Joerg
    Allegaert, Karel
    Willmann, Stefan
    CURRENT PHARMACEUTICAL DESIGN, 2015, 21 (39) : 5688 - 5698
  • [49] Physiologically-Based Pharmacokinetic Modeling and Dosing Optimization of Cefotaxime in Preterm and Term Neonates
    Li, Qiaoxi
    Guan, Yanping
    Xia, Chen
    Wu, Lili
    Zhang, Hongyu
    Wang, Yan
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 113 (08) : 2605 - 2615
  • [50] In Search of Physiologically Based Distribution Volume Estimates for Macromolecules
    Garzone, P. D.
    Atkinson, A. J., Jr.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 419 - 421